Schedule 13D ownership disclosure

Xenon Pharmaceuticals Inc

Security class unavailable · CUSIP: 98420N105

Event date: 2019-12-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-19-045741
Form type
SC 13D
Filer
NEUROCRINE BIOSCIENCES INC
CIK
CIK 914475
Filed
Dec 11, 2019
Reporting period
Dec 05, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub